|
Market Cap | 127.48M | EPS (ttm) | 1.04 |
P/E | 7.08 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 6.91% |
P/S | 1.93 | EPS next 5Y | - |
P/B | 1.03 | EPS Q/Q | -32.39% |
Dividend | 6.52% | Sales Q/Q | 3.85% |
Insider Own | 20.53% | Inst Own | 31.15% |
Insider Trans | 0.41% | Inst Trans | -5.64% |
Short Float | 0.20% | Earnings | Apr 18/a |
Analyst Recom | - | Target Price | - |
Avg Volume | 11.11K | 52W Range | 5.69 - 8.74 |
|
|
|
United Security Bancshares (California) is a holding company, which engages in the provision of commercial banking services. Its portfolio consists of commercial and industrial, government program, commercial real estate, residential mortgages, home improvement and home equity, real estate construction and development, agricultural, and installment and student loans. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company was founded in 1987 and is headquartered in Fresno, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GILL JAGROOP | Director | May 13 '24 | Buy | 7.25 | 830 | 6,018 | 1,060,322 | May 15 02:42 PM | GILL JAGROOP | Director | May 10 '24 | Buy | 7.25 | 8,080 | 58,580 | 1,059,492 | May 13 02:38 PM | WOODS DENNIS R | CEO | Apr 30 '24 | Buy | 7.05 | 2,000 | 14,100 | 880,876 | May 01 05:29 PM | GILL JAGROOP | Director | Mar 15 '24 | Buy | 7.50 | 1,137 | 8,528 | 1,051,412 | Mar 19 05:13 PM | GILL JAGROOP | Director | Mar 14 '24 | Buy | 7.50 | 18 | 135 | 1,050,275 | Mar 15 03:21 PM |
|
|
|
|
Market Cap | 106.08M | EPS (ttm) | 1.05 |
P/E | 9.00 | EPS this Y | 8.62% |
Forward P/E | 5.83 | EPS next Y | 29.10% |
PEG | 1.13 | EPS past 5Y | 12.86% |
P/S | 0.60 | EPS next 5Y | 8.00% |
P/B | 0.66 | EPS Q/Q | -30.75% |
Dividend | 5.27% | Sales Q/Q | 20.68% |
Insider Own | 17.09% | Inst Own | 57.40% |
Insider Trans | 1.30% | Inst Trans | -1.50% |
Short Float | 0.19% | Earnings | Apr 26/b |
Analyst Recom | 2.33 | Target Price | 12.33 |
Avg Volume | 11.97K | 52W Range | 8.26 - 14.24 |
|
|
|
Meridian Corp. is a bank holding company, which engages in the provision of commercial and consumer banking services. It operates through the following segments: Banking, Meridian Wealth, and Mortgage Banking. The Banking segment consists of commercial and retail banking. The Meridian Wealth segment offers wealth management services and products. The Mortgage Banking segment consists of the central loan production facility and retail and profit sharing loan production offices. The company was founded by Christopher J. Annas on June 8, 2009 and is headquartered in Malvern, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Annas Christopher J. | Chairman & CEO | May 14 '24 | Buy | 9.19 | 1,000 | 9,190 | 360,378 | May 15 02:32 PM | Holland Robert T. | Director | May 10 '24 | Buy | 9.10 | 500 | 4,550 | 76,953 | May 10 05:29 PM | Holland Robert T. | Director | May 09 '24 | Buy | 9.08 | 500 | 4,540 | 76,453 | May 10 05:29 PM | Holland Robert T. | Director | May 07 '24 | Buy | 8.97 | 1,000 | 8,975 | 75,953 | May 09 12:14 PM | Hollin Edward J. | Director | May 06 '24 | Buy | 9.13 | 500 | 4,565 | 50,626 | May 14 04:27 PM |
|
|
|
|
Market Cap | 129.48M | EPS (ttm) | -0.45 |
P/E | - | EPS this Y | 19.26% |
Forward P/E | - | EPS next Y | 29.43% |
PEG | - | EPS past 5Y | - |
P/S | 13.07 | EPS next 5Y | - |
P/B | 1.47 | EPS Q/Q | 26.18% |
Dividend | - | Sales Q/Q | 636.02% |
Insider Own | 67.06% | Inst Own | 12.31% |
Insider Trans | 0.09% | Inst Trans | -1.47% |
Short Float | 16.76% | Earnings | May 07/a |
Analyst Recom | 2.17 | Target Price | 1.87 |
Avg Volume | 860.20K | 52W Range | 0.61 - 2.12 |
|
|
|
ESS Tech, Inc. is a long-duration energy storage company, which specializes in iron flow battery technology. It develops long duration iron flow batteries for commercial and utility-scale energy storage applications requiring four or more hours of flexible energy capacity predominantly using earth-abundant materials. The company was founded by Julia Song and Craig E. Evans in January 2011 and is headquartered in Wilsonville, OR. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Teamey Kyle | Director | May 14 '24 | Buy | 0.79 | 1,250 | 987 | 173,609 | May 15 11:49 AM | Quarls Harry | Director | May 10 '24 | Buy | 0.79 | 57,310 | 44,988 | 423,456 | May 13 12:41 PM | Quarls Harry | Director | May 09 '24 | Buy | 0.84 | 42,690 | 35,817 | 366,146 | May 09 08:44 PM | Hossfeld Rich | Director | Mar 15 '24 | Buy | 0.73 | 2,500 | 1,814 | 147,873 | Mar 18 04:19 PM |
|
|
| |
|
Market Cap | 62.40M | EPS (ttm) | 0.69 |
P/E | 2.01 | EPS this Y | -3950.00% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.70 | EPS Q/Q | 73.18% |
Dividend | - | Sales Q/Q | - |
Insider Own | 12.52% | Inst Own | 57.45% |
Insider Trans | 15.80% | Inst Trans | -6.02% |
Short Float | 0.42% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 2.00 |
Avg Volume | 221.56K | 52W Range | 0.57 - 1.70 |
|
|
May-15-24 11:27AM
|
Avrobio Insider Bought Shares Worth $971,493, According to a Recent SEC Filing
(MT Newswires) +6.20% |
May-13-24 09:53AM
|
AVRO Stock Earnings: Avrobio Beats EPS for Q1 2024
(InvestorPlace) +9.76% |
Feb-27-24 10:50AM
|
Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm
(PR Newswire) |
Feb-01-24 02:25PM
|
Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm
(PR Newswire) |
Jan-31-24 10:40AM
|
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates TAST, AVRO, CALB
(GlobeNewswire) +9.57% |
06:42AM
|
Avrobios road ends in reverse merger with Tim Springer-backed startup
(BioPharma Dive) |
Jan-30-24 02:52PM
|
Avrobio's corporate tremor attracts Tectonic for reverse merger
(FierceBiotech.com) -16.06% |
02:38PM
|
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AVRO, CALB, BCAL
(PR Newswire) |
08:00AM
|
AVROBIO and Tectonic Therapeutic Announce Merger
(Business Wire) |
Nov-08-23 09:40AM
|
Is AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?
(Zacks) |
|
Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Leonard Braden Michael | 10% Owner | May 14 '24 | Buy | 1.30 | 296,882 | 385,947 | 4,768,262 | May 15 11:21 AM | Leonard Braden Michael | 10% Owner | May 13 '24 | Buy | 1.25 | 469,753 | 585,546 | 4,471,380 | May 15 11:21 AM | Golipour Azadeh | Chief Technology Officer | Feb 01 '24 | Option Exercise | 0.00 | 37,334 | 0 | 68,104 | Feb 05 08:01 PM | Ostrowski Erik | Interim CEO, President and CFO | Feb 01 '24 | Option Exercise | 0.00 | 40,084 | 0 | 42,384 | Feb 05 07:57 PM | Ridha Essra | Chief Medical Officer | Feb 01 '24 | Option Exercise | 0.00 | 32,834 | 0 | 32,834 | Feb 05 07:59 PM |
|
|
|
|
Market Cap | 346.71M | EPS (ttm) | 1.55 |
P/E | 9.07 | EPS this Y | 12.16% |
Forward P/E | 6.58 | EPS next Y | 11.71% |
PEG | 3.02 | EPS past 5Y | -0.24% |
P/S | 1.27 | EPS next 5Y | 3.00% |
P/B | 1.48 | EPS Q/Q | -16.44% |
Dividend | 5.42% | Sales Q/Q | 41.92% |
Insider Own | 6.74% | Inst Own | 37.75% |
Insider Trans | 0.90% | Inst Trans | -10.44% |
Short Float | 8.17% | Earnings | May 06/a |
Analyst Recom | 2.67 | Target Price | 13.75 |
Avg Volume | 151.16K | 52W Range | 10.07 - 19.36 |
|
|
May-13-24 11:00AM
|
NewtekOne, Inc. To Hold Analyst and Investor Day, Thursday, June 13, 2024 at its Headquarters in Boca Raton, Florida
(GlobeNewswire) |
May-08-24 04:19PM
|
Newtek Business Services Corp. (NASDAQ:NEWT) Q1 2024 Earnings Call Transcript
(Insider Monkey) |
03:13AM
|
NewtekOne Inc (NEWT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations and ...
(GuruFocus.com) |
May-06-24 04:05PM
|
NewtekOne, Inc. Reports First Quarter 2024 Financial Results
(GlobeNewswire) |
May-02-24 09:00AM
|
"Apiture Innovator" Awards Announced at Apiture Accelerate 2024 Conference
(ACCESSWIRE) |
Apr-23-24 08:30AM
|
NewtekOne, Inc. CEO, Barry Sloane, to Attend the B. Riley Securities 24th Institutional Investor Conference May 22-23, 2024
(GlobeNewswire) |
Apr-04-24 10:10AM
|
NewtekOne, Inc. to Report First Quarter 2024 Financial Results on Monday, May 6, 2024 After the Market Closes
(GlobeNewswire) +5.85% |
Apr-01-24 10:15AM
|
NewtekOne, Inc. Promotes Frank M. DeMaria to Chief Accounting Officer
(GlobeNewswire) |
10:15AM
|
NewtekOne, Inc. Hires Taylor Quinn as Chief Risk Officer
(GlobeNewswire) |
10:15AM
|
NewtekOne, Inc. Announces Loan Closings for the First Quarter 2024
(GlobeNewswire) |
|
NewtekOne, Inc. is a financial holding company, which engages in the provision of business and financial solutions. Its brands include Newtek Bank, Newtek Lending, Newtek Payments, Newtek Insurance, Newtek Payroll, and Newtek Technology. The company was founded by Barry Sloane in 1998 and is headquartered in Boca Raton, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SLOANE BARRY | Chairman & CEO | May 15 '24 | Buy | 14.17 | 10,000 | 141,716 | 1,130,674 | May 15 10:03 AM | Zink Gregory L | Director | May 15 '24 | Buy | 14.15 | 1,000 | 14,152 | 28,085 | May 15 10:34 AM | Mulia Salvatore Francis | Director | Apr 22 '24 | Sale | 10.87 | 750 | 8,152 | 46,462 | Apr 23 04:14 PM | Mulia Salvatore Francis | Director | Mar 21 '24 | Sale | 10.71 | 750 | 8,033 | 47,212 | Mar 22 04:04 PM | Mulia Salvatore Francis | Director | Feb 21 '24 | Sale | 11.48 | 750 | 8,610 | 47,962 | Feb 21 05:12 PM |
|
|
| |
|
Market Cap | 388.25M | EPS (ttm) | 0.24 |
P/E | 24.93 | EPS this Y | -79.37% |
Forward P/E | 15.86 | EPS next Y | 192.31% |
PEG | 6.23 | EPS past 5Y | 21.58% |
P/S | 1.21 | EPS next 5Y | 4.00% |
P/B | 0.44 | EPS Q/Q | -25.31% |
Dividend | 7.30% | Sales Q/Q | 9.48% |
Insider Own | 12.10% | Inst Own | 63.64% |
Insider Trans | 0.25% | Inst Trans | -11.79% |
Short Float | 1.82% | Earnings | Apr 25/b |
Analyst Recom | 3.00 | Target Price | 6.25 |
Avg Volume | 456.10K | 52W Range | 5.28 - 9.46 |
|
|
|
Kearny Financial Corp. operates as a holding company, which engages in the ownership and operation of Kearny Bank. Its services include deposits from the general public in New Jersey. The firm uses deposits, together with other funds, to originate or purchase loans for its portfolio and invest in securities. It offers both personal and business services. The company was founded in 1884 and is headquartered in Fairfield, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Pivirotto Charles J | Director | May 13 '24 | Buy | 5.76 | 5,160 | 29,739 | 59,573 | May 15 09:44 AM | Suchodolski Keith | SEVP and CFO | Mar 18 '24 | Buy | 5.87 | 2,000 | 11,740 | 82,648 | Mar 18 11:16 AM | BILOTTA ANTHONY V JR | EVP and Chief Banking Officer | Mar 18 '24 | Buy | 5.85 | 2,000 | 11,700 | 79,761 | Mar 18 11:14 AM | Joyce Patrick M | EVP and CLO | Mar 14 '24 | Sale | 6.17 | 3,500 | 21,597 | 48,331 | Mar 14 01:51 PM | Wong-Zaza Melvina | Director | Feb 14 '24 | Buy | 6.47 | 3,945 | 25,515 | 6,595 | Feb 15 09:45 AM |
|
|
|
|
Market Cap | 119.89M | EPS (ttm) | -1.37 |
P/E | - | EPS this Y | 9.79% |
Forward P/E | - | EPS next Y | -9.30% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 8.55 | EPS Q/Q | 8.40% |
Dividend | - | Sales Q/Q | - |
Insider Own | 60.93% | Inst Own | 8.53% |
Insider Trans | 0.09% | Inst Trans | 28.35% |
Short Float | 13.17% | Earnings | May 07/b |
Analyst Recom | 1.00 | Target Price | 22.00 |
Avg Volume | 105.12K | 52W Range | 5.92 - 18.65 |
|
|
|
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BENTSUR RON | Chairman & CEO | May 14 '24 | Buy | 6.74 | 1,940 | 13,076 | 3,246,424 | May 15 09:16 AM | BENTSUR RON | Chairman & CEO | May 10 '24 | Buy | 6.40 | 2,000 | 12,800 | 3,244,484 | May 13 08:51 AM | Shemesh Shay | Chief Dev. & Ops. Officer | May 10 '24 | Buy | 6.32 | 1,113 | 7,034 | 1,493,068 | May 13 08:47 AM | Poradosu Enrique | Chief Science & Business Off | May 10 '24 | Buy | 6.29 | 500 | 3,145 | 1,504,319 | May 13 08:49 AM | BENTSUR RON | Chairman & CEO | Mar 18 '24 | Buy | 10.29 | 5,000 | 51,450 | 3,242,484 | Mar 19 08:00 AM |
|
|
| |
|
Market Cap | 310.37M | EPS (ttm) | -0.37 |
P/E | - | EPS this Y | 42.18% |
Forward P/E | 123.17 | EPS next Y | 127.81% |
PEG | - | EPS past 5Y | - |
P/S | 0.56 | EPS next 5Y | 15.00% |
P/B | 1.82 | EPS Q/Q | 30.41% |
Dividend | - | Sales Q/Q | 3.15% |
Insider Own | 32.36% | Inst Own | 23.91% |
Insider Trans | 1.86% | Inst Trans | 1.08% |
Short Float | 0.18% | Earnings | May 08/a |
Analyst Recom | 1.00 | Target Price | 8.00 |
Avg Volume | 19.30K | 52W Range | 3.00 - 5.33 |
|
|
|
Lesaka Technologies, Inc. is a South African financial technology company which focuses on delivering financial services to consumers (B2C) and merchants (B2B) in Southern Africa through proprietary banking and payment technologies. Its services include banking, lending and insurance solutions to consumers, cash management solutions, bill payment technology, value-added services, business funding and card acquiring solutions to formal and informal retail merchants. The company was founded by Serge Christian Pierre Belamant in 1989 and is headquartered in Johannesburg, South Africa. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Mazanderani Ali | Executive Chairman | May 14 '24 | Buy | 5.14 | 52,418 | 269,429 | 374,894 | May 15 09:11 AM | Mazanderani Ali | Director | Dec 12 '23 | Buy | 3.30 | 322,476 | 1,064,171 | 322,476 | Dec 13 04:09 PM | Value Capital Partners (Pty) L | Director | Jun 29 '23 | Buy | 3.57 | 7,303 | 26,072 | 15,642,598 | Jul 03 04:01 PM | Value Capital Partners (Pty) L | Director | Jun 21 '23 | Buy | 3.60 | 1,200 | 4,320 | 15,635,295 | Jun 26 07:57 PM | Value Capital Partners (Pty) L | Director | May 25 '23 | Buy | 3.59 | 400 | 1,436 | 15,634,095 | May 30 08:32 PM |
|
|
|
|
Market Cap | 669.31M | EPS (ttm) | -1.01 |
P/E | - | EPS this Y | -41.78% |
Forward P/E | 17.54 | EPS next Y | 45.96% |
PEG | - | EPS past 5Y | - |
P/S | 0.38 | EPS next 5Y | - |
P/B | 0.71 | EPS Q/Q | 58.55% |
Dividend | - | Sales Q/Q | -3.71% |
Insider Own | 1.40% | Inst Own | 99.06% |
Insider Trans | 2.74% | Inst Trans | 5.17% |
Short Float | 4.22% | Earnings | May 08/b |
Analyst Recom | 2.47 | Target Price | 9.62 |
Avg Volume | 1.45M | 52W Range | 5.68 - 14.05 |
|
|
|
The Hain Celestial Group, Inc. engages in the production and distribution of organic and natural products. It operates through North America and International geographical segments. The North America segment consists of the United States and Canada. The International segment includes the United Kingdom, Ella's Kitchen UK, and Europe. The company was founded by Irwin David Simon on May 19, 1993 and is headquartered in Hoboken, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Boyce Lee A. | EVP & Chief Financial Officer | May 13 '24 | Buy | 7.67 | 13,500 | 103,478 | 13,500 | May 15 08:36 AM | Marquardt Chad D. | President, North America | May 10 '24 | Buy | 6.95 | 10,000 | 69,500 | 10,000 | May 13 08:34 AM | Davidson Wendy P | President and CEO | May 10 '24 | Buy | 6.99 | 5,000 | 34,934 | 63,309 | May 13 08:31 AM | Davidson Wendy P | President and CEO | Feb 13 '24 | Buy | 9.46 | 5,000 | 47,294 | 58,309 | Feb 14 04:19 PM | ZIER DAWN M. | Director | Nov 15 '23 | Buy | 11.25 | 5,000 | 56,250 | 68,755 | Nov 16 04:30 PM |
|
|
|
|
Market Cap | 3.39B | EPS (ttm) | -6.84 |
P/E | - | EPS this Y | -27.46% |
Forward P/E | - | EPS next Y | 10.06% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 10.43 | EPS Q/Q | -112.85% |
Dividend | - | Sales Q/Q | - |
Insider Own | 13.74% | Inst Own | 84.28% |
Insider Trans | 3.62% | Inst Trans | 334.79% |
Short Float | 11.70% | Earnings | May 09/a |
Analyst Recom | 1.09 | Target Price | 58.67 |
Avg Volume | 1.41M | 52W Range | 13.53 - 62.21 |
|
|
|
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
CHILDS JOHN W | Director | May 13 '24 | Buy | 35.17 | 28,500 | 1,002,470 | 2,283,341 | May 14 07:30 AM | Bailey Gregory | Director | May 13 '24 | Buy | 34.19 | 15,000 | 512,877 | 1,615,071 | May 15 07:31 AM | Bailey Gregory | Director | Apr 24 '24 | Buy | 39.18 | 25,503 | 999,169 | 1,600,071 | Apr 25 07:32 AM | CHILDS JOHN W | Director | Apr 22 '24 | Buy | 41.00 | 195,121 | 7,999,961 | 4,096,512 | Apr 23 07:54 AM | Coric Vlad | Chief Executive Officer | Apr 22 '24 | Buy | 41.00 | 121,951 | 4,999,991 | 1,788,417 | Apr 23 07:54 AM |
|
|
|